Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortOnce-daily DOAC for stroke prevention in AF and for clots.Twice-daily blood thinner without routine monitoring.
Body systemBlood & ClottingBlood & Clotting
Drug classDirect oral anticoagulantsDirect oral anticoagulants
SupplyPrescription onlyPrescription only
Main usesStroke prevention in atrial fibrillation, Deep vein thrombosis and pulmonary embolismStroke prevention in atrial fibrillation, Deep vein thrombosis and pulmonary embolism, Clot prevention after hip or knee replacement
How it worksThins the blood by blocking factor Xa.Blocks one key clotting protein directly.
Starts working1–2 hours3–4 hours
Half-life10–14 hoursAbout 12 hours
Typical adult dose60 mg once a day; 30 mg once a day if kidney clearance 15–50 mL/min, weight 60 kg or less or certain interacting medicines.AF: 5 mg twice a day (2.5 mg if two of: age ≥80, weight ≤60 kg, poor kidney function). Clot treatment: 10 mg twice a day for 7 days, then 5 mg twice a day.
FormsTabletTablet
Common side effectsBleeding, Bruising, Anaemia, NauseaBruising, Nosebleeds, Heavy periods
Serious side effectsMajor bleeding, Bleeding in the brain, Spinal haematomaMajor bleeding, Bleeding in the brain (less than with warfarin)
Don't take ifActive bleeding; Severe liver disease with coagulopathy; Uncontrolled severe high blood pressure; Mechanical heart valvesActive major bleeding; Severe liver disease with clotting abnormalities; Mechanical heart valve; Taking strong CYP3A4 and P-gp inhibitors (ketoconazole, ritonavir) without review
AlcoholBest to limit. Heavy drinking raises bleeding risk.Best to limit. Alcohol raises bleeding risk.
PregnancyUsually avoidedAvoid in pregnancy.Usually avoidedNot used in pregnancy; low-molecular-weight heparin is preferred.
BreastfeedingUsually avoidedNot recommended.Usually avoidedAvoid.
In use since—2012
Brand namesUnited States: SavaysaUnited Kingdom: LixianaIndia: LixianaUnited States: EliquisUnited Kingdom: EliquisIndia: Eliquis, Apigat
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeB01AF03B01AF02

Taken together

  • MajorEdoxaban + Apixaban: Double anticoagulation — serious bleeding risk

    Two blood thinners together greatly increase the risk of major bleeding.

Open in the interaction checker